Orioles infielder Chris Davis received a therapeutic-use exemption for 2015, but not for Adderall, according to FoxSports.com.

Instead, Davis received an exemption for Vyvanse, which is also used to treat attention-deficit disorder. Davis tested positive for Adderall last season, leading to a 25-game suspension. Vyvanse is less likely to be abused for non-therapeutic reasons, according to MLB doctors, which is why it's been suggested over Adderall. 

Davis has tried the new drug this winter, and said it's worked well thus far. "That was part of the process – try the Vyvanse to see I liked it, if I liked it better or wanted to go back to Adderall," Davis said. "I liked Vyvanse better."

Davis still has one game left on his suspension, and will miss opening day this year. After that, Davis said he's "good to go." 

The 28-year-old hit .196/.300/.404 over 450 at-bats last year.